
How a UK big pharma exec was arrested in China – and hasn’t been heard from since
It was an announcement that shocked the corporate world – wiping £14bn from the share price of Britain’s biggest company in a single day, and demonstrating the risks of doing business in China. Last November, AstraZeneca admitted that one of its top …